Dataset Information

State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

ABSTRACT: Integrated approaches using different in vitro methods in combination with bioinformatics can (i) increase the success rate and speed of drug development; (ii) improve the accuracy of toxicological risk assessment; and (iii) increase our understanding of disease. Three-dimensional (3D) cell culture models are important building blocks of this strategy which has emerged during the last years. The majority of these models are organotypic, i.e., they aim to reproduce major functions of an organ or organ system. This implies in many cases that more than one cell type forms the 3D structure, and often matrix elements play an important role. This review summarizes the state of the art concerning commonalities of the different models. For instance, the theory of mass transport/metabolite exchange in 3D systems and the special analytical requirements for test endpoints in organotypic cultures are discussed in detail. In the next part, 3D model systems for selected organs--liver, lung, skin, brain--are presented and characterized in dedicated chapters. Also, 3D approaches to the modeling of tumors are presented and discussed. All chapters give a historical background, illustrate the large variety of approaches, and highlight up- and downsides as well as specific requirements. Moreover, they refer to the application in disease modeling, drug discovery and safety assessment. Finally, consensus recommendations indicate a roadmap for the successful implementation of 3D models in routine screening. It is expected that the use of such models will accelerate progress by reducing error rates and wrong predictions from compound testing.

SUBMITTER: Alepee N

PROVIDER: S-EPMC4783151 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Alépée Natalie N Bahinski Anthony A Daneshian Mardas M De Wever Bart B Fritsche Ellen E Goldberg Alan A Hansmann Jan J Hartung Thomas T Haycock John J Hogberg Helena H Hoelting Lisa L Kelm Jens M JM Kadereit Suzanne S McVey Emily E Landsiedel Robert R Leist Marcel M Lübberstedt Marc M Noor Fozia F Pellevoisin Christian C Petersohn Dirk D Pfannenbecker Uwe U Reisinger Kerstin K Ramirez Tzutzuy T Rothen-Rutishauser Barbara B Schäfer-Korting Monika M Zeilinger Katrin K Zurich Marie-Gabriele MG

ALTEX 20140714 4

Integrated approaches using different in vitro methods in combination with bioinformatics can (i) increase the success rate and speed of drug development; (ii) improve the accuracy of toxicological risk assessment; and (iii) increase our understanding of disease. Three-dimensional (3D) cell culture models are important building blocks of this strategy which has emerged during the last years. The majority of these models are organotypic, i.e., they aim to reproduce major functions of an organ or ...[more]

PMID: 25027500

Similar Datasets

Project description:ObjectiveThe edge chipping test is used to measure the fracture resistance of dental restoration ceramics and resin composites. This paper focuses on the progress of evaluating chipping resistance of these materials and also on the progress of standardization of this test method. This paper also makes observations about the state of the art of mechanical testing of ceramic and composite restorative materials in general. Interlaboratory comparative studies ("round robins") are recommended.MethodsAn edge chipping machine was used to evaluate dozens of materials including porcelains, glass ceramics, aluminas, zirconias, filled resin-composites, new hybrid ceramic-resin composites, laminated composite ceramics, and even polymethyl methacrylate based denture materials. Force versus distance data was collected over a broad range with different indenters. Several chipping resistance parameters were quantified.ResultsOlder restorative materials such as feldspathic porcelains and veneering materials had limited chipping resistance, but more modern ceramics and filled composites show significant improvements. A yttria-partially stabilized zirconia had the greatest resistance to chipping. Much of the early work on edge chipping resistance of brittle materials emphasized linear force versus distance trends obtained with relatively blunt Rockwell C indenters. More recently, trends for dental restorative materials with alternative sharper indenters have been nonlinear. A new phenomenological model with a simple quadratic function fits all data exceptionally well. It is loosely based on an energy balance between indenter work and fracture and deformation energies in the chipped material.SignificanceAlthough a direct comparison of our laboratory scale tests on idealized simple geometries to clinical outcomes has not yet been done, anecdotal evidence suggests the procedure does produce clinically relevant rankings and outcomes. Despite the variations in the trends and indenters, comparisons between materials can easily be made by chipping convenient block-shaped specimens with sharp conical 120°, Vickers, or Rockwell C indenters at a defined edge distance of 0.5mm. Broad distance ranges are recommended for trend evaluation. This work has provided important information for standardization.

Project description:PurposeA limit on developing new treatments for a number of central nervous system (CNS) disorders has been the inadequate understanding of the in vivo pathophysiology underlying neurological and psychiatric disorders and the lack of in vivo tools to determine brain penetrance, target engagement, and relevant molecular activity of novel drugs. Molecular neuroimaging provides the tools to address this. This article aims to provide a state-of-the-art review of new PET tracers for CNS targets, focusing on developments in the last 5 years for targets recently available for in-human imaging.MethodsWe provide an overview of the criteria used to evaluate PET tracers. We then used the National Institute of Mental Health Research Priorities list to identify the key CNS targets. We conducted a PubMed search (search period 1st of January 2013 to 31st of December 2018), which yielded 40 new PET tracers across 16 CNS targets which met our selectivity criteria. For each tracer, we summarised the evidence of its properties and potential for use in studies of CNS pathophysiology and drug evaluation, including its target selectivity and affinity, inter and intra-subject variability, and pharmacokinetic parameters. We also consider its potential limitations and missing characterisation data, but not specific applications in drug development. Where multiple tracers were present for a target, we provide a comparison of their properties.Results and conclusionsOur review shows that multiple new tracers have been developed for proteinopathy targets, particularly tau, as well as the purinoceptor P2X7, phosphodiesterase enzyme PDE10A, and synaptic vesicle glycoprotein 2A (SV2A), amongst others. Some of the most promising of these include 18F-MK-6240 for tau imaging, 11C-UCB-J for imaging SV2A, 11C-CURB and 11C-MK-3168 for characterisation of fatty acid amide hydrolase, 18F-FIMX for metabotropic glutamate receptor 1, and 18F-MNI-444 for imaging adenosine 2A. Our review also identifies recurrent issues within the field. Many of the tracers discussed lack in vivo blocking data, reducing confidence in selectivity. Additionally, late-stage identification of substantial off-target sites for multiple tracers highlights incomplete pre-clinical characterisation prior to translation, as well as human disease state studies carried out without confirmation of test-retest reproducibility.

Dataset Information

State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Publications

State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets